The federal 340B drug pricing program is failing to meet the needs of the vulnerable patients the program was intended to ...

Proximity, founded by a Kalderos alum, identifies savings opportunities and potential compliance issues for health care ...

The industry could see payment, workforce and insurance coverage changes depending on how the Trump administration weighs in ...

When the 340B program was first launched, pharmaceutical manufacturers were to provide medications at a discounted price for ...

In the final days of 2024, three pharmaceutical giants sued the federal government. In their joint lawsuit, Amgen, Eli Lilly ...

The bill would tie prescription drug prices to federally negotiated rates under a program passed in the 1990s.

In his welcoming remarks, AHA President and CEO Rick Pollack discussed some of the immediate threats to rural hospitals' well ...

Rather than serving as a lifeline for vulnerable patients, 340B has become a profit-generating machine for large hospital systems, many of which are exploiting the program for financial gain ...

The U.S. Supreme Court’s ruling in American Hospital Association (“AHA”) v. Becerra (2022) sent shockwaves through the 340B drug pricing program ...

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we ...

House Bill 1003 author, Rep. Brad Barrett (R-Richmond), said the bill is built on six key pillars: lower costs; fight waste, ...